Skip to main content

Closing in on a new treatment for sleeping sickness.

Publication ,  Journal Article
Derbyshire, ER; Clardy, J
Published in: eLife
July 2013

A chemoproteomics approach has been employed to identify a kinase that could be used as a druggable target in efforts to develop new treatments for African sleeping sickness.

Duke Scholars

Published In

eLife

DOI

EISSN

2050-084X

ISSN

2050-084X

Publication Date

July 2013

Volume

2

Start / End Page

e01042

Related Subject Headings

  • Zearalenone
  • Trypanosoma brucei brucei
  • Fungi
  • Antiprotozoal Agents
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 31 Biological sciences
  • 0601 Biochemistry and Cell Biology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Derbyshire, E. R., & Clardy, J. (2013). Closing in on a new treatment for sleeping sickness. ELife, 2, e01042. https://doi.org/10.7554/elife.01042
Derbyshire, Emily R., and Jon Clardy. “Closing in on a new treatment for sleeping sickness.ELife 2 (July 2013): e01042. https://doi.org/10.7554/elife.01042.
Derbyshire ER, Clardy J. Closing in on a new treatment for sleeping sickness. eLife. 2013 Jul;2:e01042.
Derbyshire, Emily R., and Jon Clardy. “Closing in on a new treatment for sleeping sickness.ELife, vol. 2, July 2013, p. e01042. Epmc, doi:10.7554/elife.01042.
Derbyshire ER, Clardy J. Closing in on a new treatment for sleeping sickness. eLife. 2013 Jul;2:e01042.

Published In

eLife

DOI

EISSN

2050-084X

ISSN

2050-084X

Publication Date

July 2013

Volume

2

Start / End Page

e01042

Related Subject Headings

  • Zearalenone
  • Trypanosoma brucei brucei
  • Fungi
  • Antiprotozoal Agents
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 31 Biological sciences
  • 0601 Biochemistry and Cell Biology